Klingman & Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $388K | Buy |
4,234
+116
| +3% | +$10.1K | 0.02% | 232 |
|
|
2026
Q1 | $351K | Buy |
4,118
+188
| +5% | +$16.8K | 0.02% | 240 |
|
|
2025
Q4 | $311K | Buy |
3,930
+321
| +9% | +$25.2K | 0.02% | 249 |
|
|
2025
Q3 | $289K | Sell |
3,609
-126
| -3% | -$10.7K | 0.01% | 259 |
|
|
2025
Q2 | $340K | Buy |
3,735
+169
| +5% | +$15.4K | 0.02% | 229 |
|
|
2025
Q1 | $334K | Buy |
3,566
+147
| +4% | +$13.2K | 0.02% | 208 |
|
|
2024
Q4 | $311K | Sell |
3,419
-25
| -0.7% | -$2.39K | 0.02% | 201 |
|
|
2024
Q3 | $358K | Buy |
3,444
+32
| +0.9% | +$3.26K | 0.02% | 198 |
|
|
2024
Q2 | $331K | Buy |
3,412
+49
| +1% | +$4.52K | 0.02% | 184 |
|
|
2024
Q1 | $303K | Hold |
3,363
| – | – | 0.02% | 192 |
|
|
2023
Q4 | $268K | Sell |
3,363
-13
| -0.4% | -$977 | 0.02% | 196 |
|
|
2023
Q3 | $240K | Buy |
3,376
+435
| +15% | +$32.5K | 0.02% | 202 |
|
|
2023
Q2 | $227K | Buy |
2,941
+45
| +2% | +$3.48K | 0.02% | 199 |
|
|
2023
Q1 | $218K | Sell |
2,896
-110
| -4% | -$8.18K | 0.02% | 188 |
|
|
2022
Q4 | $237K | Buy |
3,006
+2
| +0.1% | +$150 | 0.02% | 180 |
|
|
2022
Q3 | $211K | Buy |
3,004
+86
| +3% | +$6.74K | 0.02% | 176 |
|
|
2022
Q2 | $234K | Buy |
2,918
+63
| +2% | +$4.93K | 0.02% | 172 |
|
|
2022
Q1 | $216K | Buy |
2,855
+34
| +1% | +$2.69K | 0.02% | 192 |
|
|
2021
Q4 | $241K | Buy |
+2,821
| New | +$220K | 0.02% | 162 |
|
|
2021
Q2 | – | Sell |
-2,613
| Closed | -$206K | – | 164 |
|
|
2021
Q1 | $206K | Buy |
+2,613
| New | +$205K | 0.02% | 162 |
|
|
2016
Q4 | – | Sell |
-1,670
| Closed | -$124K | – | 140 |
|
|
2016
Q3 | $124K | Sell |
1,670
-341
| -17% | -$25.2K | 0.04% | 122 |
|
|
2016
Q2 | $147K | Hold |
2,011
| – | – | 0.05% | 110 |
|
|
2016
Q1 | $142K | Hold |
2,011
| – | – | 0.05% | 113 |
|
|
2015
Q4 | $134K | Sell |
2,011
-600
| -23% | -$39.9K | 0.05% | 137 |
|
|
2015
Q3 | $165K | Sell |
2,611
-200
| -7% | -$13.1K | 0.06% | 124 |
|
|
2015
Q2 | $184K | Hold |
2,811
| – | – | 0.07% | 89 |
|
|
2015
Q1 | $195K | Hold |
2,811
| – | – | 0.08% | 86 |
|
|
2014
Q4 | $194K | Buy |
+2,811
| New | +$190K | 0.08% | 85 |
|
Other funds holding CL
Klingman & Associates's CL Position: Q2 2026 in Review
Klingman & Associates increased its Colgate-Palmolive (CL) stake by 2.8% in Q2 2026, buying an estimated $10.1K and bringing the position to 4,234 shares worth $388K. The position accounts for 0.02% of the portfolio, ranked #232.
Klingman & Associates first reported a position in CL in Q4 2014 and has held it in 28 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Klingman & Associates held 4,234 shares of Colgate-Palmolive worth $388K as of Q2 2026.
- Klingman & Associates bought 116 Colgate-Palmolive shares in Q2 2026, an estimated $10.1K.
- Colgate-Palmolive made up 0.02% of Klingman & Associates's portfolio in Q2 2026, its #232 holding.
- Klingman & Associates first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 28 quarters since.
- 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Klingman & Associates's 13F filing for Q2 2026, filed 29 Jul 2026.